Search Results

Site Search

Lung Cancer NGS Panel - Mayo Clinic Laboratories

Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.

MayoComplete - Insights

Browse our menu of MayoComplete next-generation sequencing assays which are designed to identify a growing list of hematological cancers.

Thrombotic microangiopathy (TMA) - Insights

View our comprehensive testing suite designed to confirm diagnosis and facilitate treatment of thrombotic microangiopathy.

Chromosomal microarray - Insights

Learn how our microarray evaluations identify, analyze, and assess clinically significant chromosomal abnormalities.

Hereditary epilepsy - Insights

Find out how we perform in-depth mutation and copy number variant analysis to determine causes of epilepsy and identify potential treatment options.

The Expanding Reach of the Laboratory Outreach Program - Insights

The most successful laboratory outreach programs recognize the importance of serving multiple customers. From provider to patient to healthcare consumer, the laboratory has an opportunity to serve them all with high-quality results and...

Meet Me at the Microscope at USCAP 2020 - Insights

Mayo Clinic pathologists, researchers, and a wide spectrum of allied health staff will be in Los Angeles, California, for the 109th United States and Canadian Academy of Pathology Meeting (USCAP). Visit us at booth #716 on March 2 - 4, 2020...

Bobbi Pritt, M.D., Comments on Blacklegged Ticks in Minnesota Conservation Volunteer - Insights

Blacklegged ticks (also known as deer ticks) are turning up more frequently in Minnesota, and so are the diseases they carry. Bobbi Pritt, a parasitologist in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester,...

FISH testing - Insights

Find out how our streamlined approach to fluorescence in situ hybridization testing can simplify the ordering process and better meet patient needs.

Alzheimer's Disease 2024: The Role of Biomarkers - Insights

PACE/State of FL This webinar, with expert presenters having both extensive lab and clinical experience, will discuss the latest updates in Alzheimer’s disease diagnostic criteria as well as a comprehensive review of the laboratory testing...